PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.62%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
6.88%
Positive gross profit growth while VALMT.HE is negative. John Neff would see a clear operational edge over the competitor.
12.52%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
12.52%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
-9.83%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-9.52%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-9.52%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.08%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.08%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
80.06%
OCF growth under 50% of VALMT.HE's 1700.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
798.98%
FCF growth above 1.5x VALMT.HE's 506.67%. David Dodd would verify if the firm’s strategic investments yield superior returns.
14.23%
10Y revenue/share CAGR under 50% of VALMT.HE's 70.39%. Michael Burry would suspect a lasting competitive disadvantage.
11.52%
5Y revenue/share CAGR under 50% of VALMT.HE's 46.76%. Michael Burry would suspect a significant competitive gap or product weakness.
19.20%
3Y revenue/share CAGR at 50-75% of VALMT.HE's 30.65%. Martin Whitman would question if the firm lags behind competitor innovations.
222.39%
10Y OCF/share CAGR under 50% of VALMT.HE's 3485.79%. Michael Burry would worry about a persistent underperformance in cash creation.
323.88%
Below 50% of VALMT.HE's 790.30%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
64.02%
Positive 3Y OCF/share CAGR while VALMT.HE is negative. John Neff might see a big short-term edge in operational efficiency.
856.85%
Net income/share CAGR above 1.5x VALMT.HE's 381.55% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
27.58%
Below 50% of VALMT.HE's 621.76%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
218.95%
3Y net income/share CAGR above 1.5x VALMT.HE's 92.17%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
162.49%
10Y equity/share CAGR 1.25-1.5x VALMT.HE's 113.15%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
72.58%
5Y equity/share CAGR at 50-75% of VALMT.HE's 126.65%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
53.08%
3Y equity/share CAGR at 50-75% of VALMT.HE's 86.17%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-100.00%
Cut dividends over 10 years while VALMT.HE stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.30%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
7.14%
Inventory growth well above VALMT.HE's 8.24%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.87%
Asset growth well under 50% of VALMT.HE's 2.81%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-6.05%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.29%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Our R&D shrinks while VALMT.HE invests at 7.41%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.92%
We cut SG&A while VALMT.HE invests at 60.69%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.